- WeTrade Group ( NASDAQ: WETG ) said it will sell monkeypox virus test kits and antigen tests for $50M to Parkway Medical.
- Under the agreement, Parkway agreed to buy 5M units of nucleic acid test (RT-LAMP) and 6M units of antigen tests (Colloidal Golden Technique) for a total worth $50M, and Parkway has paid $1M as deposit.
- "We are excited about the sales of monkeypox virus kits and antigen tests to Parkway Medical after obtaining the exclusive sales channel from Jiqing Biomedical Technology Co. Ltd," said WeTrade CEO Pijun Liu.
- WETG +11.19% to $16.00 premarket Aug. 12
For further details see:
WeTrade stock rises 11% on $50M sales contract for monkeypox test kits